 |
| SEC Chair Gary Gensler |
The Securities and Exchange Commission on May 31 charged SCWorx Corp and its former CEO Mark Schessel with making false and misleading claims on an April 13 press release about the New York company’s plan to distribute COVID-19 rapid test kits.
The complaint alleges that SCWorx falsely stated that it had a committed purchase order for two million kits.
The order, according to the release, had “a provision for additional weekly orders of two million units for 23 weeks, valued at $35M per week.”
Following the issuance of the release, SCWorx’s stock surged 425 percent from the prior trading day on volume of 96.2M shares, which was more than 900 times the prior three-month average daily volume, according to the SEC.
The SEC alleges that Schessel and SCWorx issued the release despite having neither a legitimate supplier of COVID-19 test kits nor an executed purchase agreement with a buyer.
The complaint also alleges that Schessel and SCWorx publicly repeated the false and misleading statements about the distribution of COVID-19 rapid test kits over the course of April 2020.
"We allege that the defendants engaged in an age-old fraud—lying about their business prospects—to capitalize opportunistically on the COVID pandemic," SEC Chair Gary Gensler said in a statement. "As the challenges from the pandemic continue, investors should be vigilant about COVID-related claims. The SEC will continue to root out fraud and prosecute those who attempt to use the surge of uncertainty from the pandemic to defraud the investing public."
SCWorx has agreed to a settlement, subject to court approval, that includes permanent injunctions, the payment of a $125,000 penalty, and disgorgement of $471,000 with prejudgment interest of $32,761.56.
As PR firms fall over themselves setting up cannabis practices to cash in on the legalized marijuana market, a British speciality drug company stands ready to treat potheads.
Indivior and its French partner Aelis Farma on May 31 enrolled its first patient in a Phase 2 study for its synthetic inhibitor drug to treat cannabis use disorder (CUD).
It hopes to win the first US approval for a medicine to treat excessive marijuana use.
Cannabis is the No. 3 misused substance after alcohol and tobacco.
About 50M Americans used cannabis in 2020 and 14M of them had CUD.
Indivior CEO Mark Crossly told the Financial Times that “there is going to be a huge opportunity for us to help people with this disorder, moving forward, especially with so many people nowadays seeing marijuana as a normalized space.”
UK’s Tulchan handles Indivior’s PR.
 |
Concerned about your shrinking retirement fund? Don’t fret. It could be worse. You could be a billionaire.
Check out Bloomberg Billionaires Index for a scorecard on how the stock market swoon has ravished the wealth of the super affluent.
While the Dow Jones Industrial Average is down 10.3 percent this year, Bloomberg’s top billionaire, Elon Musk, is down 46.8B smackers to $224B because his investment portfolio is focused largely on Tesla.
Investors are spooked that Musk’s infatuation with Twitter will come at the expense of Tesla, which trades at $739.20. The stock has traded at between $571.22 and $1,243 during the past year..
No 2 billionaire Amazon’s Jeff Bezos, is down $48.3B to $144B and No. 4 Microsoft co-founder Bill Gates dropped $15.3B to $123B.
Facebook CEO Mark Zuckerberg tumbled to the No. 13 spot as his portfolio of Meta stock dipped $54.1B to $71.5B.
The billionaires, though, may have the last laugh as rising interest rates spread financial misery to the common folk.
The top one percent owns more than half of US stock and mutual funds, while the bottom 90 percent owns less than 12 percent.
It’s a different story when it comes to real estate.
The bottom 90 percent own more than half of the real estate, while the top one percenters control less than 14 percent, according to the Federal Reserve.
The National Association of Realtors on May 26 reported that pending home sales slid 3.9 percent in April, which was the sixth consecutive down month.
The Federal Reserve promises that interest rates are going to get higher.
Lawrence Yun, NAR’s chief economist, notes that higher mortgage rates are “even more problematic to a family on a budget contending with rapid inflation, including surging fuel and food costs.”
Hold tight, we’re in for some nasty weather.
A huge PR opportunity looms for a firm that is willing to take some heat by promoting Immigration & Customs Enforcement... Disgraced New York mayor Eric Adams couldn't wait to make another pilgrimage to Israel to stick it to his successor Zohran Mamdani... Hats off to Berkshire Hathaway’s Warren Buffett for writing his always engaging and witty annual reports over the years.
The ADL plans a Mamdani Monitor to track down any whiff of antisemitism from the policies and appointments made by his administration. It should have given him a chance to live up to Election Night promise... Brendan Carr, Alden Global Capital, Alphabet, Meta and Elon Musk make Reporters Without Borders' roster of Press Freedom Predators.
Andrew Cuomo's political career is not dead yet... Steve Bannon says Republicans should learn from Zohran Mamdani and his Working Families Party and Democratic Socialists of America, instead of mocking them... Internet advertising model is on the way out, says Tim Berners-Lee... Gannet rebrands as USA Today Inc. What about its other 200 papers?
Thomas Jefferson warned about the dangers of an imperial president who would deny an election loss in a bid to cling to power. Sound familiar?... Defense Secretary Pete Hegseth says reporters don't need his permisson to take a photo of the Pentagon's 9/11 memorial, as long as they are not on the job... Kirkland and Ellison lawyers need some negotiating tips. 
Shareholder activitism is poised to hit an all-time high for 2025... Kamala Harris’ “107 Days” reads like an autospsy of her failed presidential run. Democrats need to look forward, not backward... The Reagan Foundation dishonored The Gipper by providing PR cover to tariff-loving Trump.
